Funding for this research was provided by:
National Natural Science Foundation of China (81571705)
Beijing Nova Program (Z171100001117020)
National Key Research and Development Program of China (2017YFC1308900)
NationalNatural Science Foundation of China (81671733)
NationaNatural Science Foundation of China (81871386)
Beijing Municipal Administration of Hospitals-Yangfan Project (ZYLX201816)
Beijing Natural Science Foundation, JingJin-Ji special projects for basic research cooperation (H2018206600)
Beijing Excellent Talents Funding (2017000021223ZK33)
Received: 15 August 2019
Accepted: 23 December 2019
First Online: 9 January 2020
Compliance with ethical standards
: The authors declare no potential conflict of interests.
: All procedures in this study were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and its later versions. Informed consent, or its equivalent, was obtained from all patients included in the study. The clinical study was approved by the Ethics Committee of the Beijing Cancer Hospital (Ethics Approval License: 2018KT48).
: All institutional and national guidelines for the care and use of laboratory animals were followed.
: Informed consent was obtained from the 6 individual participants included in this study.
Free to read: This content has been made available to all.